Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial.
van Driel WJ, Ressing ME, Kenter GG, Brandt RM, Krul EJ, van Rossum AB, Schuuring E, Offringa R, Bauknecht T, Tamm-Hermelink A, van Dam PA, Fleuren GJ, Kast WM, Melief CJ, Trimbos JB. van Driel WJ, et al. Among authors: van dam pa, van rossum ab. Eur J Cancer. 1999 Jun;35(6):946-52. doi: 10.1016/s0959-8049(99)00048-9. Eur J Cancer. 1999. PMID: 10533477 Clinical Trial.
Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study.
Algera MD, Slangen BFM, van Driel WJ, Wouters MWJM, Kruitwagen RFPM; participants of the Dutch Gynecological Oncology Audit Collaborator Group. Algera MD, et al. Among authors: van driel wj. Gynecol Oncol. 2023 Jul;174:89-97. doi: 10.1016/j.ygyno.2023.04.021. Epub 2023 May 9. Gynecol Oncol. 2023. PMID: 37167897 Free article.
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.
Ressing ME, van Driel WJ, Celis E, Sette A, Brandt MP, Hartman M, Anholts JD, Schreuder GM, ter Harmsel WB, Fleuren GJ, Trimbos BJ, Kast WM, Melief CJ. Ressing ME, et al. Among authors: van driel wj. Cancer Res. 1996 Feb 1;56(3):582-8. Cancer Res. 1996. PMID: 8564975
The current status of therapeutic HPV vaccine.
van Driel WJ, Ressing ME, Brandt RM, Toes RE, Fleuren GJ, Trimbos JB, Kast WM, Melief CJ. van Driel WJ, et al. Ann Med. 1996 Dec;28(6):471-7. doi: 10.3109/07853899608999110. Ann Med. 1996. PMID: 9017105 Review.
Immunotherapeutic strategies for cervical squamous carcinoma.
van Driel WJ, Kenter GG, Fleuren GJ, Melief CJ, Trimbos BJ. van Driel WJ, et al. Hematol Oncol Clin North Am. 1999 Feb;13(1):259-73. doi: 10.1016/s0889-8588(05)70164-7. Hematol Oncol Clin North Am. 1999. PMID: 10080080 Review.
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.
Ressing ME, van Driel WJ, Brandt RM, Kenter GG, de Jong JH, Bauknecht T, Fleuren GJ, Hoogerhout P, Offringa R, Sette A, Celis E, Grey H, Trimbos BJ, Kast WM, Melief CJ. Ressing ME, et al. Among authors: van driel wj. J Immunother. 2000 Mar-Apr;23(2):255-66. doi: 10.1097/00002371-200003000-00010. J Immunother. 2000. PMID: 10746552
105 results